NCT07528586 2026-04-14
CMR-Onko
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Phase NA Recruiting
Clinical Trials
115 trialsNCT06183437 2026-03-30
STOP-MED CTRCD
University Health Network, Toronto
Phase 4 Recruiting
NCT06778122 2026-03-27
BREATHS
University College, London
Phase NA Recruiting
NCT07442578 2026-03-18
PULSE
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT07405385 2026-02-12
CARE-BREAST
University of Castilla-La Mancha
Phase NA Not yet recruiting
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT04928261 2026-01-22
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT06595147 2026-01-08
BE-FITTER
University of Alberta
Phase NA Recruiting
NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
NCT06023576 2026-01-02
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT02696707 2025-12-18
OTT 15-05
Ottawa Hospital Research Institute
Phase 4 Completed
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
NCT05023785 2025-11-26
HIMALAYAS
University Health Network, Toronto
Phase NA Recruiting
NCT05271162 2025-11-21
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Recruiting
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT04023110 2025-10-09
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting
NCT06888505 2025-09-18
DAPA-AIC
Hawler Medical University
Phase 2 Completed
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04892667 2025-08-13
DETECT
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT05029154 2025-06-12
Exercise Preconditioning in Ovarian Cancer
University of Virginia
Phase NA Terminated
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT06310330 2025-06-06
TRUST-ACE
Norwegian University of Science and Technology
Phase NA Recruiting
NCT06986291 2025-05-29
CorTox
Technische Universität Dresden
Phase NA Not yet recruiting
NCT06930521 2025-04-16
JUSTIFY
Women's College Hospital
Phase NA Not yet recruiting
NCT05406635 2025-04-08
HER2BIC
Odense University Hospital
Phase NA Recruiting
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting
NCT06881940 2025-03-18
CARPTOX-BC
Instituto Nacional de Cardiologia Ignacio Chavez
Phase NA Not yet recruiting
NCT05465031 2025-03-14
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Phase 4 Recruiting
NCT05781672 2025-02-19
SpeckleAnthra2
University Hospital, Montpellier
Phase NA Terminated
NCT05403736 2025-02-06
CARMA
Cedars-Sinai Medical Center
Phase NA Completed
NCT05699915 2025-01-30
CAVACI
Algemeen Ziekenhuis Maria Middelares
Phase NA Terminated
NCT03934905 2024-11-20
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Texas Tech University Health Sciences Center
Phase 1/2 Recruiting
NCT06684509 2024-11-12
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Assiut University
Phase 1/2 Not yet recruiting
NCT05703126 2024-11-05
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Samara State Medical University
Phase NA Recruiting
NCT04486573 2024-10-22
Cardiac Effects From Radiation Therapy by MRI
University of Colorado, Denver
Phase NA Completed
NCT06622954 2024-10-02
PROTECT-COR
Erasmus Medical Center
Phase NA Recruiting
NCT06595316 2024-09-19
Exercise for Ameliorating Chemotherapy Cardiotoxicity
University of Hull
Phase NA Not yet recruiting
NCT03748550 2024-08-21
EXACT2
Nova Scotia Health Authority
Phase NA Active not recruiting
NCT03486340 2024-07-08
CATCH
Vejle Hospital
Phase NA Completed
NCT04939883 2024-06-28
CardioTox
Hospital Sirio-Libanes
Phase 4 Unknown
NCT05467111 2024-04-11
CardioProtEx
Technical University of Madrid
Phase NA Recruiting
NCT06341842 2024-04-02
PROTECT
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 2 Unknown
NCT06340516 2024-04-01
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
Vastra Gotaland Region
Phase NA Recruiting